An expert provided an overview of BRAF mutations in lung cancer. The recent approval by the Food and Drug Administration (FDA) of BRAF inhibitor Braftovi ...
An expert on prostate cancer gives a brief overview of castrate-resistant prostate cancer.
This summer marked my 5-year anniversary of being diagnosed with cancer. It’s almost eerie to think that it has been that long since my diagnosis. During ...
Rashid K. Sayyid, MD, MSc, gives a brief overview of treatment options for nonmetastatic castrate-resistant prostate cancer.
After receiving a cancer and autoimmune diagnosis, Andy became more vigilant about his health — especially during the COVID-19 pandemic. After surviving ...
Expert perspectives on the treatment approach for patients with metastatic castrate-resistant prostate cancer.
When all that training’s done, what does it mean for patients? The experience of having a scan or biopsy shouldn’t change at all. But the image or ...
Tian Zhang, MD, MHS, provides an overview of the treatment of patients with non–clear cell renal cell carcinoma.
In part one of CURE’s “Breaking Barriers: Addressing Women of Color Underrepresentation in Clinical Trials” webinar, Ricki Fairley, CEO of TOUCH, The Black ...
In part two of CURE’s “Breaking Barriers: Addressing Women of Color Underrepresentation in Clinical Trials” webinar, Ricki Fairley, CEO of TOUCH, The Black ...
In part three of CURE’s “Breaking Barriers: Addressing Women of Color Underrepresentation in Clinical Trials” webinar, Ricki Fairley, CEO of TOUCH, The ...
In part four of CURE’s “Breaking Barriers: Addressing Women of Color Underrepresentation in Clinical Trials” webinar, Ricki Fairley, CEO of TOUCH, The Black ...